Literature DB >> 33533915

Persistent cellular immunity to SARS-CoV-2 infection.

Gaëlle Breton1, Pilar Mendoza1, Thomas Hägglöf1, Thiago Y Oliveira1, Dennis Schaefer-Babajew1, Christian Gaebler1, Martina Turroja1, Arlene Hurley2, Marina Caskey1, Michel C Nussenzweig1,3.   

Abstract

SARS-CoV-2 is responsible for an ongoing pandemic that has affected millions of individuals around the globe. To gain further understanding of the immune response in recovered individuals, we measured T cell responses in paired samples obtained an average of 1.3 and 6.1 mo after infection from 41 individuals. The data indicate that recovered individuals show persistent polyfunctional SARS-CoV-2 antigen-specific memory that could contribute to rapid recall responses. Recovered individuals also show enduring alterations in relative overall numbers of CD4+ and CD8+ memory T cells, including expression of activation/exhaustion markers, and cell division.
© 2021 Breton et al.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33533915      PMCID： PMC7845919          DOI： 10.1084/jem.20202515

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  45 in total

Review 1.  Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8(+) T cells during cytomegalovirus infection.

Authors:  Christopher M Snyder
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.

Authors:  Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus A Mall; Kirsten Beyer; Jobst Röhmel; Sebastian Voigt; Jürgen Schmitz; Stefan Miltenyi; Ilja Demuth; Marcel A Müller; Andreas Hocke; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif Erik Sander; Andreas Thiel
Journal:  Nature       Date:  2020-07-29       Impact factor: 49.962

3.  Age-specific mortality and immunity patterns of SARS-CoV-2.

Authors:  Simon Cauchemez; Henrik Salje; Megan O'Driscoll; Gabriel Ribeiro Dos Santos; Lin Wang; Derek A T Cummings; Andrew S Azman; Juliette Paireau; Arnaud Fontanet
Journal:  Nature       Date:  2020-11-02       Impact factor: 49.962

Review 4.  A brief history of T cell help to B cells.

Authors:  Shane Crotty
Journal:  Nat Rev Immunol       Date:  2015-02-13       Impact factor: 53.106

5.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Authors:  Divij Mathew; Josephine R Giles; Amy E Baxter; Derek A Oldridge; Allison R Greenplate; Jennifer E Wu; Cécile Alanio; Leticia Kuri-Cervantes; M Betina Pampena; Kurt D'Andrea; Sasikanth Manne; Zeyu Chen; Yinghui Jane Huang; John P Reilly; Ariel R Weisman; Caroline A G Ittner; Oliva Kuthuru; Jeanette Dougherty; Kito Nzingha; Nicholas Han; Justin Kim; Ajinkya Pattekar; Eileen C Goodwin; Elizabeth M Anderson; Madison E Weirick; Sigrid Gouma; Claudia P Arevalo; Marcus J Bolton; Fang Chen; Simon F Lacey; Holly Ramage; Sara Cherry; Scott E Hensley; Sokratis A Apostolidis; Alexander C Huang; Laura A Vella; Michael R Betts; Nuala J Meyer; E John Wherry
Journal:  Science       Date:  2020-07-15       Impact factor: 47.728

Review 6.  The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance.

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Cell Infect Microbiol       Date:  2019-06-13       Impact factor: 5.293

7.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

8.  Comprehensive mapping of immune perturbations associated with severe COVID-19.

Authors:  Leticia Kuri-Cervantes; M Betina Pampena; Wenzhao Meng; Aaron M Rosenfeld; Caroline A G Ittner; Ariel R Weisman; Roseline S Agyekum; Divij Mathew; Amy E Baxter; Laura A Vella; Oliva Kuthuru; Sokratis A Apostolidis; Luanne Bershaw; Jeanette Dougherty; Allison R Greenplate; Ajinkya Pattekar; Justin Kim; Nicholas Han; Sigrid Gouma; Madison E Weirick; Claudia P Arevalo; Marcus J Bolton; Eileen C Goodwin; Elizabeth M Anderson; Scott E Hensley; Tiffanie K Jones; Nilam S Mangalmurti; Eline T Luning Prak; E John Wherry; Nuala J Meyer; Michael R Betts
Journal:  Sci Immunol       Date:  2020-07-15

9.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Authors:  Takuya Sekine; André Perez-Potti; Olga Rivera-Ballesteros; Kristoffer Strålin; Jean-Baptiste Gorin; Annika Olsson; Sian Llewellyn-Lacey; Habiba Kamal; Gordana Bogdanovic; Sandra Muschiol; David J Wullimann; Tobias Kammann; Johanna Emgård; Tiphaine Parrot; Elin Folkesson; Olav Rooyackers; Lars I Eriksson; Jan-Inge Henter; Anders Sönnerborg; Tobias Allander; Jan Albert; Morten Nielsen; Jonas Klingström; Sara Gredmark-Russ; Niklas K Björkström; Johan K Sandberg; David A Price; Hans-Gustaf Ljunggren; Soo Aleman; Marcus Buggert
Journal:  Cell       Date:  2020-08-14       Impact factor: 41.582

10.  Duration of antibody responses after severe acute respiratory syndrome.

Authors:  Li-Ping Wu; Nai-Chang Wang; Yi-Hua Chang; Xiang-Yi Tian; Dan-Yu Na; Li-Yuan Zhang; Lei Zheng; Tao Lan; Lin-Fa Wang; Guo-Dong Liang
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883
View more
  43 in total

Review 1.  Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19.

Authors:  M Barnova; A Bobcakova; V Urdova; R Kosturiak; L Kapustova; D Dobrota; M Jesenak
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

2.  SARS-CoV-2 infection generates tissue-localized immunological memory in humans.

Authors:  Maya M L Poon; Ksenia Rybkina; Yu Kato; Masaru Kubota; Rei Matsumoto; Nathaniel I Bloom; Zeli Zhang; Kathryn M Hastie; Alba Grifoni; Daniela Weiskopf; Steven B Wells; Basak B Ural; Nora Lam; Peter A Szabo; Pranay Dogra; Yoon S Lee; Joshua I Gray; Marissa C Bradley; Maigan A Brusko; Todd M Brusko; Erica O Saphire; Thomas J Connors; Alessandro Sette; Shane Crotty; Donna L Farber
Journal:  Sci Immunol       Date:  2021-11-19

3.  New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021.

Authors:  Thomas R Martin; Rachel L Zemans; Lorraine B Ware; Eric P Schmidt; David W H Riches; Lisa Bastarache; Carolyn S Calfee; Tushar J Desai; Susanne Herold; Catherine L Hough; Mark R Looney; Michael A Matthay; Nuala Meyer; Samir M Parikh; Troy Stevens; B Taylor Thompson
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

4.  Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.

Authors:  Min Zhao; Rebecca Slotkin; Amar H Sheth; Lauren Pischel; Tassos C Kyriakides; Brinda Emu; Cynthia McNamara; Qiaosu Shi; Jaden Delgobbo; Jin Xu; Elizabeth Marhoffer; Aleagia Mercer-Falkoff; Jürgen Holleck; David Ardito; Richard E Sutton; Shaili Gupta
Journal:  Clin Infect Dis       Date:  2022-05-26       Impact factor: 20.999

5.  Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals.

Authors:  Nadejda Beliakova-Bethell; Kathirvel Maruthai; Ruijie Xu; Liliana C M Salvador; Ankita Garg
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

6.  Molecular and Serologic Diagnostic Technologies for SARS-CoV-2.

Authors:  Halie M Rando; Christian Brueffer; Ronan Lordan; Anna Ada Dattoli; David Manheim; Jesse G Meyer; Ariel I Mundo; Dimitri Perrin; David Mai; Nils Wellhausen; Covid-Review Consortium; Anthony Gitter; Casey S Greene
Journal:  ArXiv       Date:  2022-04-26

7.  Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.

Authors:  Aljawharah Alrubayyi; Ester Gea-Mallorquí; Emma Touizer; Dan Hameiri-Bowen; Jakub Kopycinski; Bethany Charlton; Natasha Fisher-Pearson; Luke Muir; Annachiara Rosa; Chloe Roustan; Christopher Earl; Peter Cherepanov; Pierre Pellegrino; Laura Waters; Fiona Burns; Sabine Kinloch; Tao Dong; Lucy Dorrell; Sarah Rowland-Jones; Laura E McCoy; Dimitra Peppa
Journal:  Res Sq       Date:  2021-03-17

8.  Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.

Authors:  Natalia Sherina; Antonio Piralla; Likun Du; Hui Wan; Makiko Kumagai-Braesch; Juni Andréll; Sten Braesch-Andersen; Irene Cassaniti; Elena Percivalle; Antonella Sarasini; Federica Bergami; Raffaella Di Martino; Marta Colaneri; Marco Vecchia; Margherita Sambo; Valentina Zuccaro; Raffaele Bruno; Michele Sachs; Tiberio Oggionni; Federica Meloni; Hassan Abolhassani; Federico Bertoglio; Maren Schubert; Miranda Byrne-Steele; Jian Han; Michael Hust; Yintong Xue; Lennart Hammarström; Fausto Baldanti; Harold Marcotte; Qiang Pan-Hammarström
Journal:  Med (N Y)       Date:  2021-02-10

Review 9.  Insights into the virologic and immunologic features of SARS-COV-2.

Authors:  Ceylan Polat; Koray Ergunay
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

10.  Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.

Authors:  Holger Lingel; Stefan Meltendorf; Ulrike Billing; Christoph Thurm; Katrin Vogel; Christiane Majer; Florian Prätsch; Dirk Roggenbuck; Hans-Gert Heuft; Thomas Hachenberg; Eugen Feist; Dirk Reinhold; Monika C Brunner-Weinzierl
Journal:  J Autoimmun       Date:  2021-06-21       Impact factor: 7.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.